Salivary gland neoplasms

Current Treatment Options in Oncology

Volumn 5, Issue 1, 2004, Pages 11-26

  Day, Terry A ^a   Deveikis, John ^b   Gillespie, M Boyd ^b   Joe, John K ^b   Ogretmen, Besim ^b   Osguthorpe, J David ^b   Reed, Susan G ^b   Richardson, Mary S ^b   Rossi, Michael ^b   Saini, Ranjiv ^b   Sharma, Anand K ^b   Stuart, Robert K ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; APREPITANT; ASPARTATE AMINOTRANSFERASE; CARBOPLATIN; CISPLATIN; CYTOCHROME P450 3A; CYTOCHROME P450 INHIBITOR; DOCETAXEL; IMATINIB; ITRACONAZOLE; KI 67 ANTIGEN; MANNITOL; MOLECULAR MARKER; NAVELBINE; ONDANSETRON; PACLITAXEL; PHENYTOIN; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; PROTEIN TYROSINE KINASE INHIBITOR; STEM CELL FACTOR RECEPTOR; TRASTUZUMAB; VORICONAZOLE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ACUTE RESPIRATORY TRACT DISEASE; ALOPECIA; ANEMIA; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASPIRATION BIOPSY; ASTHENIA; BEAM THERAPY; BONE MARROW SUPPRESSION; CANCER GRADING; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CHROMOSOME TRANSLOCATION; CHRONOTHERAPY; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DIET THERAPY; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG DOSE REGIMEN; DRUG MECHANISM; DRUG TARGETING; ELECTROLYTE DISTURBANCE; ENZYME INHIBITION; FACIAL NERVE; GRANULOCYTOPENIA; HEARING LOSS; HISTOPATHOLOGY; HUMAN; HYPOCALCEMIA; HYPOMAGNESEMIA; HYPONATREMIA; HYPOPHOSPHATEMIA; INJECTION SITE; INJECTION SITE REACTION; INTERSTITIAL LUNG DISEASE; INTESTINE OBSTRUCTION; KIDNEY DISEASE; LIFESTYLE; LIVER DYSFUNCTION; LIVER TOXICITY; MORBIDITY; NEPHROTOXICITY; NEUROMUSCULAR DISEASE; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE DISEASE; PANCREATITIS; PARALYTIC ILEUS; PAROTIDECTOMY; PERIPHERAL NEUROPATHY; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE CARE; QUALITY OF LIFE; RETINA DISEASE; REVIEW; SALIVARY GLAND CANCER; SALIVARY GLAND TUMOR; SIDE EFFECT; THROMBOCYTOPENIA; TINNITUS; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; GENETICS; METHODOLOGY; PATHOLOGY; SURGERY;

CHEMOTHERAPY, ADJUVANT; HUMANS; RADIOTHERAPY, ADJUVANT; SALIVARY GLAND NEOPLASMS; SURGICAL PROCEDURES, OPERATIVE;

EID: 1542650923     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-004-0002-x     Document Type: Review

References (82)

1. Brandwein MS, Ferlito A, Bradley PJ, et al.: Diagnosis and classification of salivary neoplasms: pathologic challenges and relevance to clinical outcomes. Acta Otolaryngol 2002, 122:758-764.
2. Speight PM, Barrett AW: Salivary gland tumours. Oral Dis 2002, 8:229-240.
3. Seifert G, Sobin LH: The World Health Organization's Histological Classification of Salivary Gland Tumors: a commentary on the second edition. Cancer 1992, 70:379-385.
4. Swanson GM, Burns PB: Cancers of the salivary gland: workplace risks among women and men. Ann Epidemiol 1997, 7:369-374.
5. Pinkston JA, Cole P: Incidence rates of salivary gland tumors: results from a population-based study. Otolaryngol Head Neck Surg 1999, 120:834-840.
6. Califano J, Eisele DW: Benign salivary gland neoplasms. Otolaryngol Clin North Am 1999, 32:861-873.
7. Ries LA, Hankey BF, Miller BA, et al.: Cancer Statistics Review 1973-1988. Bethesda: National Cancer Institute; 1991.
8. Rice DH: Malignant salivary gland neoplasms. Otolaryngol Clin North Am 1999, 32:875-886.
9. Zarbo RJ: Salivary gland neoplasia: a review for the practicing pathologist. Mod Pathol 2002, 15:298-323.
10. Land CE, Saku T, Hayashi Y, et al.: Incidence of salivary gland tumors among atomic bomb survivors, 1950-1987. Evaluation of radiation-related risk. Radiat Res 1996, 146:28-36.
11. Horn-Ross PL, Morrow M, Ljung BM: Diet and the risk of salivary gland cancer. Am J Epidemiol 1997, 146:171-176.
12. Saku T, Hayashi Y, Takahara O, et al.: Salivary gland tumors among atomic bomb survivors, 1950-1987. Cancer 1997, 79:1465-1475.
13. Muscat JE, Wynder EL: A case-control study of risk factors for major salivary gland cancer. Otolaryngol Head Neck Surg 1998, 118:195-198.
14. Horn-Ross PL, Ljung BM, Morrow M: Environmental factors and the risk of salivary gland cancer. Epidemiology 1997, 8:414-419.
15. Actis AB, Eynard AR: Influence of environmental and nutritional factors on salivary gland tumorigenesis with a special reference to dietary lipids. Eur J Clin Nutr 2000, 54:805-810.
16. Martinez-Madrigal F, Bosq J, Casiraghi O: Major salivary glands. In Histology for Pathologists. Edited by Sternberg SS. Philadelphia: Lippincott-Raven; 1997:405-429.
17. Batsakis JG, Regezi JA: The pathology of head and neck tumors: salivary glands, part 1. Head Neck Surg 1978, 1:59-68.
18. Dardick I, van Nostrand AW, Phillips MJ: Histogenesis of salivary gland pleomorphic adenoma (mixed tumor) with an evaluation of the role of the myoepithelial cell. Hum Pathol 1982, 13:62-75.
19. Mukunyadzi P: Review of fine-needle aspiration cytology of salivary gland neoplasms, with emphasis on differential diagnosis. Am J Clin Pathol 2002, 118:S100-S115.
20. Therkildsen MH, Christensen M, Andersen LJ, et al.: Salivary gland carcinomas: prognostic factors. Acta Oncol 1998, 37:701-713.
21. Bhattacharyya N, Fried MP: Nodal metastasis in major salivary gland cancer: predictive factors and effects on survival. Arch Otolaryngol Head Neck Surg 2002, 128:904-908.
22. Francioso F, Carinci F, Tosi L, et al.: Identification of differentially expressed genes in human salivary gland tumors by DNA microarrays. Mol Cancer Ther 2002, 1:533-538.
23. Bullerdiek J, Wobst G, Meyer-Bolte K, et al.: Cytogenetic subtyping of 220 salivary gland pleomorphic adenomas: correlation to occurrence, histological subtype, and in vitro cellular behavior. Cancer Genet Cytogenet 1993, 65:27-31.
24. Astrom AK, Voz ML, Kas K, et al.: Conserved mechanism of PLAG1 activation in salivary gland tumors with and without chromosome 8q12 abnormalities: identification of SII as a new fusion partner gene. Cancer Res 1999, 59:918-923.
25. Kas K, Voz ML, Roijer E, et al.: Promoter swapping between the genes for a novel zinc finger protein and beta-catenin in pleiomorphic adenomas with t(3;8)(p21;q12) translocations. Nat Genet 1997, 15:170-174.
26. Schoenmakers EF, Wanschura S, Mols R, et al.: Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nat Genet 1995, 10:436-444.
27. Kulaksiz H, Rehberg E, Stremmel W, Cetin Y: Guanylin and functional coupling proteins in the human salivary glands and gland tumors: expression, cellular localization, and target membrane domains. Am J Pathol 2002, 161:655-664.
28. Choi CS, Choi G, Jung KY, et al.: Low expression of p27(Kip1) in advanced mucoepidermoid carcinomas of head and neck. Head Neck 2001, 23:292-297.
29. Yin HF, Okada N, Takagi M: Apoptosis and apoptotic-related factors in mucoepidermoid carcinoma of the oral minor salivary glands. Pathol Int 2000, 50:603-609.
30. Gibbons MD, Manne U, Carroll WR, et al.: Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands. Laryngoscope 2001, 111:1373-1378.
31. Sandros J, Stenman G, Mark J: Cytogenetic and molecular observations in human and experimental salivary gland tumors. Cancer Genet Cytogenet 1990, 44:153-167.
32. Pinto AE, Fonseca I, Martins C, Soares J: Objective biologic parameters and their clinical relevance in assessing salivary gland neoplasms. Adv Anat Pathol 2000, 7:294-306.
33. Ma YQ, Geng JG: Obligatory requirement of sulfation for P-selectin binding to human salivary gland carcinoma Acc-M cells and breast carcinoma ZR-75-30 cells. J Immunol 2002, 168:1690-1696.
34. Toyoshima K, Kimura S, Cheng J, et al.: High-molecular-weight fibronectin synthesized by adenoid cystic carcinoma cells of salivary gland origin. Jpn J Cancer Res 1999, 90:308-319.
35. Frierson HF Jr, El-Naggar AK, Welsh JB, et al.: Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. Am J Pathol 2002, 161:1315-1323.
36. Lopes MA, Santos GC, Kowalski LP: Multivariate survival analysis of 128 cases of oral cavity minor salivary gland carcinomas. Head Neck 1998, 20:699-706.
37. Dailiana T, Chakeres D, Schmalbrock P, et al.: High-resolution MR of the intraparotid facial nerve and parotid duct. AJNR Am J Neuroradiol 1997, 18:165-172.
38. Yabuuchi H, Fukuya T, Tajima T, et al.: Salivary gland tumors: diagnostic value of gadolinium-enhanced dynamic MR imaging with histopathologic correlation. Radiology 2003, 226:345-354.
39. Keyes JW Jr, Harkness BA, Greven KM, et al.: Salivary gland tumors: pretherapy evaluation with PET. Radiology 1994, 192:99-102.
40. Greene FL, Page DL, Fleming ID, et al.: AJCC Cancer Staging Manual. New York: Springer-Verlag; 2002.
41. Orell SR: Diagnostic difficulties in the interpretation of fine needle aspirates of salivary gland lesions: the problem revisited. Cytopathology 1995, 6:285-300.
42. Pitts DB, Hilsinger RL Jr, Karandy E, et al.: Fine needle aspiration in the diagnosis of salivary gland disorders in the community hospital setting. Arch Otolaryngol Head Neck Surg 1992, 118:479-482.
43. Deans GT, Briggs K, Spence RA: An audit of surgery of the parotid gland. Ann R Coll Surg Engl 1995, 77:188-192.
44. Guyot JP, Auberson S, Obradovic D, Lehmann W: Fine needle aspiration in the diagnosis of head and neck growths: the pitfalls of false-positive diagnosis. ORL J Otorhinolaryngol Relat Spec 1993, 55:41-44.
45. Zurrida S, Alasio L, Tradati N, et al.: Fine needle aspiration of parotid masses. Cancer 1993, 72:2306-2311.
46. Stennert E, Kisner D, Jungehuelsing M, et al.: High incidence of lymph node metastasis in major salivary gland cancer. Arch Otolaryngol Head Neck Surg 2003, 129:720-723.
47. O'Brien CJ, Soong SJ, Herrera GA, et al.: Malignant salivary tumors: analysis of prognostic factors and survival. Head Neck Surg 1986, 9:82-92.
48. Ferlito A, Pellitteri PK, Robbins KT, et al.: Management of the neck in cancer of the major salivary glands, thyroid and parathyroid glands. Acta Otolaryngol 2002, 122:673-678.
49. Bensadoun RJ, Allavena C, Chauvel P, et al.: 2003 update of standards, options, and recommendations for radiotherapy for patients with salivary gland malignant tumors (excluding lymphoma, sarcoma and melanoma). Cancer Radiother 2003, 7:280-295.
50. Guzzo M, Andreola S, Sirizzotti G, Cantu G: Mucoepidermoid carcinoma of the salivary glands: clinicopathologic review of 108 patients treated at the National Cancer Institute of Milan. Ann Surg Oncol 2002, 9:688-695.
51. Friedrich RE, Bleckmann V: Adenoid cystic carcinoma of salivary and lacrimal gland origin: localization, classification, clinical pathological correlation, treatment results and long-term follow-up control in 84 patients. Anticancer Res 2003, 23:931-940.
52. Bentz BG, Hughes CA, Ludemann JP, Maddalozzo J: Masses of the salivary gland region in children. Arch Otolaryngol Head Neck Surg 2000, 126:1435-1439.
53. Sinha UK, Ng M: Surgery of the salivary glands. Otolaryngol Clin North Am 1999, 32:887-906.
54. Spiro RH: Salivary neoplasms: overview of a 35-year experience with 2807 patients. Head Neck Surg 1986, 8:177-184.
55. Johns ME, Goldsmith MM: Current management of salivary gland tumors. Part 2. Oncology (Huntingt) 1989, 3:85-91.
56. Helmus C: Subtotal parotidectomy: a 10-year review (1985-1994). Laryngoscope 1997, 107:1024-1027.
57. Garden AS, Weber RS, Morrison WH, et al.: The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation. Int J Radiat Oncol Biol Phys 1995, 32:619-626.
58. Armstrong JG, Harrison LB, Thaler HT, et al.: The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer 1992, 69:615-619.
59. Hocwald E, Korkmaz H, Yoo GH, et al.: Prognostic factors in major salivary gland cancer. Laryngoscope 2001, 111:1434-1439.
60. Andersen LJ, Therkildsen MH, Ockelmann HH, et al.: Malignant epithelial tumors in the minor salivary glands, the submandibular gland, and the sublingual gland: prognostic factors and treatment results. Cancer 1991, 68:2431-2437.
61. Anderson JN Jr, Beenken SW, Crowe R, et al.: Prognostic factors in minor salivary gland cancer. Head Neck 1995, 17:480-486.
62. Sadeghi A, Tran LM, Mark R, et al.: Minor salivary gland tumors of the head and neck: treatment strategies and prognosis. Am J Clin Oncol 1993, 16:3-8.
63. Spiro RH, Koss LG, Hajdu SI, Strong EW: Tumors of minor salivary origin: a clinicopathologic study of 492 cases. Cancer 1973, 31:117-129.
64. Vander Poorten VL, Balm AJ, Hilgers FJ, et al.: Stage as major long-term outcome predictor in minor salivary gland carcinoma. Cancer 2000, 89:1195-1204.
65. Hughes KV 3rd, Olsen KD, McCaffrey TV: Parapharyngeal space neoplasms. Head Neck 1995, 17:124-130.
66. Eisele DE, Netterville JL, Hoffman HT, Gantz BJ: Parapharyngeal space masses. Head Neck 1999, 21:154-159.
67. Armstrong JG, Harrison LB, Spiro RH, et al.: Malignant tumors of major salivary gland origin: a matched-pair analysis of the role of combined surgery and postoperative radiotherapy. Arch Otolaryngol Head Neck Surg 1990, 116:290-293.
68. Fu KK, Leibel SA, Levine ML, et al.: Carcinoma of the major and minor salivary glands: analysis of treatment results and sites and causes of failures. Cancer 1977, 40:2882-2890.
69. Guillamondegui OM, Byers RM, Luna MA, et al.: Aggressive surgery in treatment for parotid cancer: the role of adjunctive postoperative radiotherapy. Am J Roentgenol Radium Ther Nucl Med 1975, 123:49-54.
70. Harrison LB, Armstrong JG, Spiro RH, et al.: Postoperative radiation therapy for major salivary gland malignancies. J Surg Oncol 1990, 45:52-55.
71. Vikram B, Strong EW, Shah JP, Spiro RH: Radiation therapy in adenoid-cystic carcinoma. Int J Radiat Oncol Biol Phys 1984, 10:221-223.
72. Laramore GE, Krall JM, Griffin TW, et al.: Neutron versus photon irradiation for unresectable salivary gland tumors: final report of an RTOG-MRC randomized clinical trial. Radiation Therapy Oncology Group. Medical Research Council. Int J Radiat Oncol Biol Phys 1993, 27:235-240.
73. Nutting CM, Rowbottom CG, Cosgrove VP, et al.: Optimisation of radiotherapy for carcinoma of the parotid gland: a comparison of conventional, three-dimensional conformal, and intensity-modulated techniques. Radiother Oncol 2001, 60:163-172.
74. Garden AS, el-Naggar AK, Morrison WH, et al.: Postoperative radiotherapy for malignant tumors of the parotid gland. Int J Radiat Oncol Biol Phys 1997, 37:79-85.
75. Douglas JG, Koh WJ, Austin-Seymour M, Laramore GE: Treatment of salivary gland neoplasms with fast neutron radiotherapy. Arch Otolaryngol Head Neck Surg 2003, 129:944-948.
76. Gullane PJ, Havas TJ: Facial nerve grafts: effects of postoperative irradiation. J Otolaryngol 1987, 16:112-115.
77. Rentschler R, Burgess MA, Byers R: Chemotherapy of malignant major salivary gland neoplasms: a 25-year review of MD Anderson Hospital experience. Cancer 1977, 40:619-624.
78. Airoldi M, Pedani F, Succo G, et al.: Phase II randomized trial comparing vinorelbine versus vinorelbine plus cisplatin in patients with recurrent salivary gland malignancies. Cancer 2001, 91:541-547.
79. Haddad R, Colevas AD, Krane JF, et al.: Herceptin in patients with advanced or metastatic salivary gland carcinomas: a phase II study. Oral Oncol 2003, 39:724-727.
80. Airoldi M, Fornari G, Pedani F, et al.: Paclitaxel and carboplatin for recurrent salivary gland malignancies. Anticancer Res 2000, 20:3781-3783.
81. Jenning T, Li Y, Pinto H, et al.: Phase II trial of paclitaxel in advanced or metastatic salivary gland malignancies: an Eastern Cooperative Group study. Paper presented at the Annual Meeting of the Proceedings of the American Society of Clinical Oncology. San Francisco, CA; 2001.
82. Winquist E, Lamont E, Hotte S, et al.: Phase II study of imatinib mesylate in patients with adenoid cystic salivary gland carcinoma (ACC). Paper presented at the Annual Meeting of the Proceedings of the American Society of Clinical Oncology. Chicago, IL; 2003.